It has potential:
Only 10% of patients with frostbitten fingers or toes who received tissue plasminogen activator (tPA) required amputation of necrotic digits, compared with 41% of patients who didn’t get thrombolytic therapy.
It has potential:
Only 10% of patients with frostbitten fingers or toes who received tissue plasminogen activator (tPA) required amputation of necrotic digits, compared with 41% of patients who didn’t get thrombolytic therapy.
Free, and one click to unsubscribe.
Be civil and stay on topic. Your first comment is reviewed before it appears. Comments that break our comment policy are removed.
Free, and one click to unsubscribe.